P. Kaleebu

Group M consensus Gag and Nef peptides are as efficient at detecting clade A1 and D cross-subtype T-cell functions as subtype-specific consensus peptides.

R. Tweyongyere, R. Nakiboneka, S. Mugaba, 2014, Vaccine.

High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response

G. McVean, D. Gurdasani, T. Carstensen, 2022, medRxiv.

An African perspective on mucosal immunity and HIV-1

J. Gilmour, V. R. Gómez-Román, P. Pala, 2009, Mucosal Immunology.

Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae

P. Kaleebu, B. Jia, M. Betts, 2010, Journal of Virology.

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound

P. Klenerman, J. Frater, P. Goulder, 2022, Scientific Reports.

Transmitted antiretroviral drug resistance surveillance among newly HIV type 1-diagnosed women attending an antenatal clinic in Entebbe, Uganda.

P. Kaleebu, N. Ndembi, H. Grosskurth, 2008, AIDS research and human retroviruses.

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

A. Breckenridge, P. Kaleebu, D. Pillay, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa—study protocol for a mixed-methods study including a randomised controlled trial

J. Seeley, P. Kaleebu, S. Khoo, 2020, Trials.

Emerging viruses are an underestimated cause of undiagnosed febrile illness in Uganda

G. Wilkie, S. Vattipally, J. Salazar-Gonzalez, 2023, medRxiv.

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda

D. Pillay, J. Kigozi, E. Katabira, 2014, The Journal of antimicrobial chemotherapy.